Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
36 hedge funds and large institutions have $13.1M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 15 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
25% more capital invested
Capital invested by funds: $10.5M → $13.1M (+$2.62M)
16% less funds holding
Funds holding: 43 → 36 (-7)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$346K |
| 2 |
CAM
ClariVest Asset Management
San Diego,
California
|
+$188K |
| 3 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$161K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$87.5K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$83.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$109K |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
-$102K |
| 3 |
Two Sigma Advisers
New York
|
-$39K |
| 4 |
EAM
Evanson Asset Management
Carmel,
California
|
-$25K |
| 5 |
SIM
Spark Investment Management
New York
|
-$25K |
FRTX Hedge Fund Activity: Q2 2016 in Review
36 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q2 2016, worth a combined $13.1M — up 25% from $10.5M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of FRTX and 9 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 9 added.
The largest buyer was Renaissance Technologies, adding an estimated $346K. The largest seller was Fidelity Investments, cutting an estimated $109K.
- 36 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q2 2016, down from 43 in Q1 2016.
- Funds reported $13.1M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q2 2016, up 25% quarter-over-quarter.
- 9 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q2 2016 and 15 closed out, a net change of -6 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q2 2016 was Renaissance Technologies, an estimated $346K added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q2 2016 was Fidelity Investments, an estimated $109K sold.
Based on aggregated 13F filings for Q2 2016.